SEC Form 4 · accession 0000899243-15-001580
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Mark S Shearman
Officer — Chief Scientific Officer
Period of report
Jul 21, 2015
Accepted (ET)
Jul 23, 2015 · 8:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $18.48 | Jul 21, 2015 | A | 51,000 | A | — | Jul 21, 2025 | Common Stock | 51,000 | 51,000 | D |
Explanation of responses
- F1Option becomes exercisable for 20.8% of the underlying shares on June 1, 2016, and thereafter becomes exercisable for the remaining underlying shares in equal monthly installments.